Advocacy Council responds to the Proposed 2026 Medicare Physician Fee Schedule
The College’s Advocacy Council submitted formal comments to CMS on the 2026 Medicare Physician Fee Schedule proposed rule.
House committee hearing signals scrutiny ahead for Medicare Advantage
Lawmakers on both sides of the aisle expressed frustration with the current state of the Medicare Advantage (MA) program.
The College supports the CPT definition of a “dose”
We explained the background of immunotherapy and the confusion that can arise when two definitions describe the same procedure.
Traditional MIPS or MVP for allergists in 2025?
This article provides an overview of current MVP reporting options and considerations for allergists.
College launches Payer Education Campaign to halt AIT audits and claims denials
The College is proud to announce the Payer Education Campaign (PEC) that focuses on claims for allergen immunotherapy services.
2025 Medicare Physician Fee Schedule Final Rule
This article summarizes key proposals concerning the Medicare Physician Fee Schedule that impact allergy practices.
Help ensure Medicare payments cover the costs of providing care – Join our grassroots efforts!
Join us by reaching out to your representatives in Congress to enact legislation that ensures physician payments are not reduced in future updates to the Medic…
How do MACs impact patients
To process Medicare claims, MACs are awarded geographic jurisdictions in which they serve as primary contacts
2024 MIPS and APM changes
This article provides a summary of key, final changes to the QPP governing the traditional Merit-based Incentive Payment System program.
EFT fees burden physician offices
For years, physicians have faced reduced payments from commercial health plans using virtual credit cards and third-party electronic payment vendors for standa…
2024 MIPS Proposed Changes
This article provides a summary of key proposals and changes to the traditional MIPS program that will impact allergists.
2023 budget bill will result in 2% Medicare pay cut for allergists
Allergists were previously facing Medicare payment cuts of up to 8.5%, but under the budget bill, allergists will incur a 2% Medicare payment cut in 2023.
2023 Medicare reimbursement cuts
Beginning Jan. 1, 2023, allergists are facing up to a 10% reduction in Medicare reimbursement unless Congress takes legislative action to avert these cuts.
2023 Proposed MIPS Changes
For the 2023 performance year, CMS is required to weigh the cost and quality performance categories equally.
Tezspire administration remains an in-office procedure
Medicare Administrative Contractors publicly announced removal of Tezspire from their Self-Administration Drug (SAD) exclusion lists.
Drug prices lowered for Medicare beneficiaries and ACA subsidies extended
After more than a year of trying to pass the Build Back Better Act, Congress passed a slimmer version, the Inflation Reduction Act.
